Optiver Holding
IPHA

Optiver Holding’s Innate Pharma IPHA Stock Holding History

Optiver Holding’s Portfolio IPHA Stock Details IPHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-101
Closed -$197 – 2714
2025
Q3 		$197 Hold
101
– – ﹤0.01% 2581
2025
Q2 		$177 Hold
101
– – ﹤0.01% 1420
2025
Q1 		$180 Hold
101
– – ﹤0.01% 1316
2024
Q4 		$187 Sell
101
-86,687
-100% -$163K ﹤0.01% 1022
2024
Q3 		$199K Sell
86,788
-564
-0.6% -$1.25K ﹤0.01% 457
2024
Q2 		$169K Buy
87,352
+16,788
+24% +$42.2K ﹤0.01% 495
2024
Q1 		$203K Buy
70,564
+47,859
+211% +$125K ﹤0.01% 476
2023
Q4 		$63.6K Sell
22,705
-167,514
-88% -$416K ﹤0.01% 418
2023
Q3 		$481K Buy
190,219
+108,423
+133% +$318K ﹤0.01% 413
2023
Q2 		$257K Sell
81,796
-142,301
-63% -$437K ﹤0.01% 387
2023
Q1 		$636K Buy
224,097
+118,563
+112% +$381K ﹤0.01% 379
2022
Q4 		$394K Sell
105,534
-79,776
-43% -$182K ﹤0.01% 338
2022
Q3 		$371K Buy
185,310
+3,366
+2% +$9.08K ﹤0.01% 286
2022
Q2 		$491K Buy
181,944
+142,970
+367% +$416K ﹤0.01% 252
2022
Q1 		$131K Sell
38,974
-148,282
-79% -$547K ﹤0.01% 251
2021
Q4 		$1.03M Buy
187,256
+78,217
+72% +$416K ﹤0.01% 238
2021
Q3 		$673K Buy
109,039
+104,546
+2,327% +$450K ﹤0.01% 214
2021
Q2 		$15K Sell
4,493
-25,791
-85% -$103K ﹤0.01% 401
2021
Q1 		$131K Buy
+30,284
New +$135K ﹤0.01% 185

Other funds holding IPHA

Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
OMC
Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Optiver Holding's IPHA Position: Q4 2025 in Review

Optiver Holding sold out of Innate Pharma (IPHA) in Q4 2025, closing a stake of 101 shares — an estimated $197 sold.

Optiver Holding first reported a position in IPHA in Q1 2021 and held it in 19 quarters. The position peaked at $1.03M in Q4 2021. 11 funds tracked by Wall St. Rank hold IPHA as of Q4 2025.

  • Optiver Holding reported no remaining Innate Pharma position as of Q4 2025 after selling out during the quarter.
  • Optiver Holding sold 101 Innate Pharma shares in Q4 2025, an estimated $197.
  • Optiver Holding first reported a position in Innate Pharma in Q1 2021 and held it in 19 quarters.
  • Optiver Holding's Innate Pharma position peaked at $1.03M in Q4 2021.
  • 11 funds tracked by Wall St. Rank held Innate Pharma as of Q4 2025.

Based on Optiver Holding's 13F filing for Q4 2025, filed 17 Feb 2026.